Serum Institute Of India Limited

Country/Region: India     State/Province: New Delhi

Main Products: Erythropoietin, Erythropoietin

Company Introduction
To take care of optimum functioning in the security sector we have gained extra ordinary experience through our 11 Years of export history. Operating as an authorized Manufacturer and Supplier of Erythropoietin, based on Agency we take pride being listed among Erythropoietin companies that security sector relies upon. There are certain elements that demand extra attention in case of safety and security and we not only deliver quality in Erythropoietin but also ensure competitive pricing. We have evolved over time and gained reliability, helping us capture a good proportion of consumer base estimating Bangladesh,Bulgaria,Indonesia,Lithuania,Zimbabwe export market share. Effective make is another factor that we strongly believe in and maintain throughout our manufacturing cycle carried out in our professional enterprise situated in NEW DELHI, , India.Serum Institute Of India Limited LLC was introduced in the industrial sector in 2009 as a small business entity. Over the time, we have gradually evolved into a renowned Erythropoietin manufacturer with Approx More Than 1 Billion US Dollar of yearly profit, and export ratio value of US$5 Million - US$10 Million that was first launched with US$10 Million - US$50 Million initial business capital.
Company Overview

Business Type: Manufacturer

Business Nature: Manufacturer

Year Established: 2009, 2009

Legal Status: Agency

Ownership: LLC

Employees: Above 1000 People

Factory Size: Below 1, 000 square meters

R&D Team Size: Fewer than 5

Certifications: BSCI

Contact Information

Contact Person: durgesh

Designation: Managing director

Department: Owner

Telephone: 91919503000000

Business Information

Main Markets: Bulgaria (26%) Indonesia (26%) Bangladesh (18%) Zimbabwe (17%) Lithuania (11%)

Export Focus: Bangladesh, Bulgaria, Indonesia, Lithuania, Zimbabwe

Contract Services: Design Service Offered

Trade & Financial Information

Annual Revenue: Approx More Than 1 Billion US Dollar

Registered Capital: US$10 Million - US$50 Million

Export Percentage: 81% - 90%

Payment Terms: Bank wire (T/T)

Product Showcase
Erythropoietin
Erythropoietin

CL-Link > Health & Medicines in India Health & Medicines in New Delhi Medicines in India Medicines in New Delhi Erythropoietin in India Erythropoietin in New Delhi